Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CDXI one for 200 reverse split. **PPS closed at .0475.
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
Excellent! This is just the beginning. More international markets opening soon and the second generation product CDX-085 is a game changer.
Yeah there was a lot of bogus press from competitors that have inferior product. It’s been refuted and the product and company are completely legitimate. This will climb.
Get on board and hang on. We only have one direction. Mind you this is not a day trade. Get in stay in for 18 months. Upgrade your life.
I expect a pullback after this initial buy order from GNC which will be a good time to load more but this is a strategic keeper. Going to a few dollars in a couple years. Excellent product!!! Absolutely revolutionary anti-inflammatory! Try ZanthoSyn available at GNC and you will see why this stock is going up. Thanks for the tip on INMG.
Nice jump dude! I just happened to see this today, if I would of known I would of purchased. I like to diversify my investments but I have been heavily focused on, "INMG." Congratulations to your investment.
Awesome! This ones going off. Just rolled out nationwide in GNC!
Cardax! Get it now! We just went nationwide with GNC soon to be on EVERY shelf!
What I've able to research this company has potential to be a runner but pps stagnant and the board is dead. Anyone that can supply me the SS and float would be appreciated. TIA
Amazing how pure unadulterated toxic sewage spews.
6 members...small, but growing
Once we see this above 10 or 20 followers this will light up. Only matter of time cause once people realize board members from Amgen, and Novartis are behind CDXI this will run.
Just got to spread the word...news would help as well
people behind deal are big
The people on their board are real deal biotech people. Even have guy who serves on CDXI board, and also serves on Amgen board currently as well. Thats major!
Astaxanthin sounds like an interesting product and with 2 big time partnerships in BASF and Capsugel I'm a bit surprised to see this tanking and currently trading at the 52 week low.
Cardax CEO David Watumall on Stock Radio a couple days ago.
http://thestockradio.com/cdxi-cardax-inc-ceo-david-watumall/
SeeThruEquity target price $1.00
http://www.kcentv.com/story/26713309/seethruequity-initiates-research-coverage-on-cardax-inc-with-a-target-price-of-100
Boom, hit .64...load up kiddies
major names behind this stock
CDXI has former CFO of Novartis, wow!!
$CDXI Offers Alternative to Tylenol, Secures Major Partnerships
(NEW YORK)--Cardax, Inc. (OTC:CDXI), a development stage, life sciences company focused on introducing nutraceutical and pharmaceutical products aimed at reducing inflammation and oxidative stress, closes major agreements to develop new anti-inflammatory products.
Alternative to Acetaminophen (Tylenol)
As many have become aware over the past few years, the use of popular over-the-counter pain relievers containing acetaminophen, such as with Tylenol and other name brand pain relievers, has shown to cause liver damage from overuse, especially people prone to liver issues.
An example, if you did not know, it is highly recommended you don't take acetaminophen products to treat a hangover as the effects of the acetaminophen, and the bodies processing of the alcohol, has shown to cause extreme stress on the liver, and under prolonged use can cause permanent damage.
In addition, there are also issues with people with standing liver disease (unrelated to alcohol) who also can not benefit from the effects of acetaminophen as an over-the-counter pain reliever. This sets up a multi-billion dollar market for alternatives to this popular over-the-counter medicine, and CDXI has that with astaxanthin.
Experienced Board of Directors
If you want to get a good idea on why CDXI stands out from most other penny stocks, then take a look at just a sample of who sits on their Board of Directors.
Mr. George Bickerstaff held various positions with Novartis International AG, a global pharmaceuticals and consumer health company, including Chief Financial Officer of Novartis Pharma AG from October 2000 to May 2005. Ms. Tamar Howson served as Senior Vice President, Corporate and Business Development at Bristol-Myers Squibb from 2001 to 2007.
Mr. Bickerstaff and Ms. Howson, are both currently members of the Board of Directors with CDXI.
Major Partnership Agreements
CDXI recently closed partnership deals with BASF and Capsugel to develop and bring new anti-inflammatory products to market, and commercialization under revenue sharing agreements.
BASF, the world's largest chemical company, has licensed exclusive rights from CDXI for the commercialization of nature-identical, synthetic astaxanthin, ASTX-1, as a nutraceutical. With lower regulatory restrictions on nutraceuticals, the product approval and introduction should move much faster than a pharmaceutical drug, allowing BASF and CDXI to have a product available for sale in 2015.
Add together CDXI experienced Board with years of history in major pharmaceutical companies, their partnership agreements with major drug developers, and a product that provides an alternative to popular over-the-counter drugs, such as Tylenol, and CDXI may be one of those few "real deal" companies not normally found on the OTC exchange.
Also Bristol-Myers Squibb???
Tamar D. Howson , age 65, will serve as a director of the Company commencing June 16, 2014. She has served as an independent corporate business development and strategy consultant to life science companies since 2011. From 2009 to 2011, she provided business development support to life sciences companies as a member of the transaction team at JSB-Partners. From 2007 to 2008, Ms. Howson served as Executive Vice President, Corporate Business Development at Lexicon Pharmaceuticals. From 2001 to 2007, Ms. Howson served as Senior Vice President, Corporate and Business Development at Bristol-Myers Squibb.
former CFO of Novartis on CDXI board...wow!
George W. Bickerstaff, III , age 59, will serve as a director of the Company commencing June 16, 2014. Mr. Bickerstaff is currently a Managing Director of M.M. Dillon & Co., LLC, which he joined in 2005. Prior to joining M.M. Dillon & Co., LLC, Mr. Bickerstaff held various positions with Novartis International AG, a global pharmaceuticals and consumer health company, including Chief Financial Officer of Novartis Pharma AG from October 2000 to May 2005.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10053109
That's major!
Real deal company
this thing is way under the radar, and looks like a real deal company. Wouldnt be shocked to see this as acquisition target when they get a few drugs in pipeline. Still doing research...anyone know the float?
Cardax doing big things!! Google their website and check out their investor presentation.. Also have two press releases in last 2-3 weeks
Koffee Corner Inc., KOFF changed to Cardax Inc., CDXI:
http://www.otcbb.com/asp/dailylist_detail.asp?d=02/20/2014&mkt_ctg=OTCBB
Starting to get some hits, should have grabbed $1.60 but I was too slow....sigh.
Cardax closes merger; stock set to trade on Monday
http://www.staradvertiser.com/s?action=login&f=y&id=244494821
Cardax Pharmaceuticals becomes Hawaii’s 16th publicly-traded company
http://www.bizjournals.com/pacific/news/2014/02/07/cardax-pharmaceuticals-becomes.html
Merger with Cardax Pharma, Inc is complete.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9758981
This RM actually looks pretty decent for once, Cardax has had a partnership with BASF, the worlds largest chemical company for around 7 years now.
You don't see penny stocks with relationships like this every day.
http://www.bizjournals.com/pacific/stories/2006/12/04/daily6.html?page=all
Interesting looking RM coming with Cardax Pharmaceuticals
http://www.cardaxpharma.com/
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9638117
http://www.hispanicbusiness.com/2013/11/30/agreement_enables_isle-based_biotech_firm_cardax.htm
Yeah your probably right, just looks like a small coffee shop in downtown Houston that wants to raise the capital to open a couple new locations.
Wouldn't surprise me to see a stock promotion here someday.
http://www.koffeekornerinc.com/
Hummmmm will have to keep an eye on this one. Probably tank to under .10 with no volume, sit dormant for a few months, then a few spikes in volume, consolidation, then a major pump......
Followers
|
6
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
43
|
Created
|
08/17/13
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |